Genomic Health to Market Epic Sciences' AR-V7 Liquid Biopsy Test - Gen…
Genomic Health to Market Epic Sciences' AR-V7 Liquid Biopsy Test GenomeWeb Under the agreement, actual AR-V7 CTC isolation and testing will still be performed by Epic Sciences at its own CLIA lab. Genomic Health will have exclusive distribution rights to market and sell the test in the US beginning in early 2017. Results from ... 더보기 » |